Condition 101 About Neutropenia Chronic Familial

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Neutropenia Chronic Familial

Latest Advances On Neutropenia Chronic Familial

  • Condition: Primary Immune Deficiency Disorders
  • Journal: Frontiers in immunology
  • Treatment Used: Hematopoietic Stem Cell Transplantation
  • Number of Patients: 228
  • Published —
In this study, researchers evaluated the outcomes of undergoing hematopoietic stem cell transplantation for the treatment of primary immune deficiency disorders in children.
  • Condition: Chronic Lymphocytic Leukemia
  • Journal: Haematologica
  • Treatment Used: Venetoclax, Bendamustine, and Rituximab Versus Venetoclax, Bendamustine, and Obinutuzumab
  • Number of Patients: 83
  • Published —
In this study, researchers compared the effectiveness of venetoclax, bendamustine, and rituximab versus venetoclax, bendamustine, and obinutuzumab for the treatment of chronic lymphocytic leukemia.

Clinical Trials For Neutropenia Chronic Familial

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 45
  • Start Date: October 16, 2020
A Phase 1B, Open-Label, Multicenter Study of Mavorixafor in Patients With Severe Congenital Neutropenia and Chronic Neutropenia Disorders
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Procedure
  • Participants: 150
  • Start Date: January 2020
Interventional Not Pharmacological Study to Investigate the Role of ADA in Multiple Sclerosis PatientsTreated With an Immune-Reconstitution Therapy (2-CdA)